How to pass on wealth, AstraZeneca & Ceres: The Companies and Markets Show
This week, the American FDA announced it’s set to review a new breast cancer drug, Enhertu, developed by AstraZeneca (AZN) and its Japanese partner, Daiichi Sankyo. Julian Hofmann and Dan Jones unpack what this did to Astra’s shares, the wider issues facing pharmaceutical companies, plus an update on GSK’s (GSK)…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Investors' Chronicle
See all episodes →
Similar episodes from other shows
More like Investors' Chronicle →
Big companies’ big earnings, the Post Office’s new banking pilot and an Asian investment trust superstar
How to Navigate the Great Wealth Transfer
Is it time to cut inheritance tax… or raise it?
Jamie Dimon succession race narrows
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.